HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
6,830.00
+30.00 (0.44%)
Nov 17, 2026, 3:30 PM KST
HLB Pharmaceutical Revenue
HLB Pharmaceutical had revenue of 62.50B KRW in the quarter ending September 30, 2026, with 3.14% growth. This brings the company's total for the last twelve months to 253.85B, up 44.85% year-over-year. In the year 2025, HLB Pharmaceutical had annual revenue of 205.58B with 49.97% growth. That makes HLB Pharmaceutical the 17,934th largest company in the world by revenue and 912th in South Korea.
Revenue (ttm)
253.85B
Revenue Growth
+44.85%
P/S Ratio
0.88
Revenue / Employee
1.29B
Employees
197
Market Cap
224.02B
Revenue by Segment
- Pharmaceutical Manufacturing - Manufacturing and Sales 153.61B 74.7%
- Pharmaceutical Distribution 51.05B 24.8%
- Pharmaceutical Manufacturing - Other 922.90M 0.4%
Fiscal year ended Dec 31, 2025 See the full HLB Pharmaceutical breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 205.58B | 68.50B | 49.97% |
| Dec 31, 2024 | 137.08B | 100.98B | 279.73% |
| Dec 31, 2019 | 36.10B | 15.56B | 75.75% |
| Dec 31, 2018 | 20.54B | 4.98B | 32.03% |
| Dec 31, 2017 | 15.56B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| JW Holdings | 1.01T |
| Chong Kun Dang Holdings | 961.64B |
| Suheung | 765.90B |
| Daewon Pharmaceutical | 614.64B |
| Huons | 607.75B |
| Samjin Pharmaceuticals | 274.03B |
| Whan In Pharm | 273.47B |
| Korea United Pharm | 161.44B |